TET2 and neoplasm: We report a significant impact of DNA methylation loss on cell viability, accompanied by re-expression of the key tumour suppressor genes like TET2, and find no evidence supporting the emerging paradigm of ERV reactivation as a likely mediator of the observed HMA toxicity.